BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  NicOx SA Gets Boost From Strong Prospects For Glaucoma Drug Vesneo

  September 25, 2014

   · 

  8 min read
• BioMidwest

  Medtronic, Inc. Gears Up For Clinical Trial Of Smartphone-Enabled Continuous Glucose Monitor

  September 25, 2014

   · 

  1 min read
• Business

  Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus

  September 25, 2014

   · 

  1 min read
• Deals

  Exagen Diagnostics, Inc. Files For $69 Million IPO

  September 25, 2014

   · 

  1 min read
• Biotech Bay

  Emeryville Cancer Drug Developer Eureka Therapeutics Lands $21 Million From Chinese, Other Investors

  September 25, 2014

   · 

  1 min read
• BioCapital

  Pfizer Wants Black Box Warning From Chantix

  September 25, 2014

   · 

  1 min read
• Business

  MannKind Corporation Announces Closing Of Global Licensing Agreement With Sanofi (France)

  September 25, 2014

   · 

  2 min read
• Drug Development

  Advanced Cell Technology Announces Final Patient Treated In Stargardt’s Macular Degeneration Phase 1 Trial In The United Kingdom

  September 25, 2014

   · 

  1 min read
• BioMidwest

  Unique IMRIS Hybrid OR Enables Highly Complex Deformity Correction At Dartmouth Hitchcock Medical Center

  September 25, 2014

   · 

  2 min read
• Medunik Canada Announces Health Canada Priority Review Of PHEBURANE© Indicated For The Treatment Of Urea Cycle Disorders (UCD)

  September 25, 2014

   · 

  3 min read